Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase

Journal of Vascular Research

Volumn 42, Issue 4, 2005, Pages 284-291

  Benter, Ibrahim F ^a   Yousif, Mariam H M ^a   Hollins, Andrew J ^b   Griffiths, Sioned M ^b   Akhtar, Saghir ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

AG1478; Diabetes; Diadzein; Epidermal growth factor receptor; Genistein; Renal artery; Tyrosine kinase

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANGIOTENSIN; DAIDZEIN; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GENISTEIN; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GLUCOSE BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RENAL ARTERY; RENOVASCULAR DISEASE; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; VASOCONSTRICTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; DIABETIC ANGIOPATHIES; ENDOTHELIN-1; ENZYME INHIBITORS; FEMALE; RATS; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; RENAL ARTERY; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 23844545968     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085904     Document Type: Article

References (40)

1. Khamaisi M, Schrijvers BF, De Vriese AS, Raz I, Flyvbjerg A: The emerging role of VEGF in diabetic kidney disease. Nephrol Dial Transplant 2003;18:1427-1430.
2. Oyama Y, Kawasaki H, Hattori Y, Kanno M: Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 1986;132:75-78.
3. Abebe W, Harris KH, MacLeod KM: Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol 1990;16:239-248.
4. Kamata K, Miyata N, Kasuya Y: Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol 1989;97:614-618.
5. Mayhan WG, Irvine SD, Sharpe GM: Constrictor responses of resistance arterioles during diabetes mellitus. Diabetes Res Clin Pract 1999;44:147-156.
6. Makino A, Ohuchi K, Kamata K: Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat. Br J Pharmacol 2000;13:549-556.
7. Head RJ, Longhurst PA, Panek RL, Stitzel RE: A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from rat and rabbit. Br J Pharmacol 2000;91:275-286.
8. Yousif MH, Cherian A, Oriowo MA: Endothelium-dependent relaxation in isolated renal arteries of diabetic rabbits. Auton Autacoid Pharmacol 2002;22:73-82.
9. Wakabayashi I, Hatake K, Kimura N, Kakishita E, Nagai K: Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci 1987;40:643-648.
10. Bhardwaj R, Moore PK: Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats. J Pharm Pharmacol 1988;40:739-742.
11. Flyvbjerg A: Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia 2000;43:1205-1223.
12. Patel B, Hiscott P, Charteris D, Mather J, McLeod D, Boulton M: Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy. Br J Ophthalmol 1994;78:714-718.
13. Khan AJ, Fligiel SE, Liu L, Jaszewski R, Chandok A, Majumdar AP: Induction of EGFR tyrosine kinase in the gastric mucosa of diabetic rats. Proc Soc Exp Biol Med 1999;221:105-110.
14. Sayed-Ahmed N, Besbas N, Mundy J, Muchaneta-Kubara E, Cope G, Pearson C, el Nahas M: Upregulation of epidermal growth factor and its receptor in the kidneys of rats with streptozotocin-induced diabetes. Exp Nephrol 1996;4:330-339.
15. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR, Malik KU: 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent kinase II-induced mitogen-activated protein kinase activation in VSMC. Proc Natl Acad Sci USA 1998;95:12701-12706.
16. Muthalif MM, Benter IF, Khandekar Z, Gaber L, Estes A, Malik S, Parmentier JH, Manne V, Malik KU: Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension. Hypertension 2000;35:457-463.
17. Muthalif MM, Karzoun NA, Gaber L, Khandekar Z, Benter IF, Saeed AE, Parmentier JH, Estes A, Malik KU: Ang II-induced hypertension: Contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 2000;36:604-609.
18. Muthalif M, Karzoun N, Benter IF, Gaber L, Ljuca F, Uddin MR, Khandekar Z, Estes A, Malik KU: Functional significance of activation of calcium/calmodulin-dependent protein kinase II in angiotensin II-induced vascular hyperplasia and hypertension. Hypertension 2002;39:704-709.
19. Kassab E, McFarlane SI, Sowers JR: Vascular complications in diabetes and their prevention. Vasc Med 2001;6:249-255.
20. Nakajima M, Cooney MJ, Tu AH, Chang KY, Cao J, Ando A, An GJ, Melia M, de Juan E: Normalization of retinal vascular permeability in experimental diabetes with genistein. Invest Ophthalmol Vis Sci 2001;42:2110-2114.
21. Ziyadeh FN, Goldfarb S: The renal tubulointerstitium in diabetes mellitus. Kidney Int 1991;39:464-475.
22. Carmines PK, Fallet RW, Che Q, Fujiwara K: Tyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin II. Hypertension 2001;37:569-573.
23. Yousif MH, Akhtar S, Benter IF: Tyrosine kinases (TKs) and cytochrome P-450 (CYP-450) metabolites of arachidonic acid (AA) play a role in development of cardiovascular dysfunction in diabetes. J Pharm Pharmacol 2002;54:S-103.
24. Kamata K, Hosokawa M: Endothelial dysfunction in the perfused kidney from the streptozotocin-induced diabetic rat. Res Commun Mol Pathol Pharmacol 1997;96:57-70.
25. 2 of vasoconstriction induced by an α-agonist in mesenteric arterial bed from diabetic rats. Diabetologia 1998;41:1410-1418.
26. Beenen O, Mathy MJ, Pfaffendorf M, van Zwieten PA: Vascular responsiveness in isolated perfused kidneys of diabetic hypertensive rats. J Hypertens 1996;14:1125-1130.
27. Dai FX, Diederich A, Skopec J, Diederich D: Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: Role of prostaglandin endoperoxides and free radicals. J Am Soc Nephrol 1993;4:1327-1336.
28. Alabadi JA, Miranda FJ, Llorens S, de Apodaca R, Centeno J: Diabetes potentiates acetylcholine-induced relaxation in rabbit renal arteries. Eur J Pharmacol 2001;415:225-232.
29. Foon KA, Yang XD, Weiner LM, Belldegrun AS, Figlin RA, Crawford J, Rowinsky EK, Dutcher JP, Vogelzang NJ, Gollub J, Thompson JA, Schwartz G, Bukowski RM, Roskos LK, Schwab GM: Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody. Int J Radiat Oncol Biol Phys 2004;58:984-990.
30. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, Higashiyama S: Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy. Nat Med 2002;8:35-40.
31. Yan Y, Shirakabe K, Werb Z: The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol 2002;158:221-226.
32. Korc M, Matrisian LM, Nakamura R, Magun BE: Epidermal growth factor binding is altered in pancreatic acini from diabetic rats. Life Sci 1984;12:2049-2055.
33. Sissom JF, Stenzel WK, Warshaw JB: Decreased binding of epidermal growth factor in placentas from streptozotocin-diabetic rats. J Clin Invest 1987;80:242-247.
34. Okamoto M, Kahn CR, Maron R, White MF: Decreased autophosphorylation of EGF receptor in insulin-deficient diabetic rats. Am J Physiol 1988;254:E429-E434.
35. Yang ML, Guh JY, Lai YH, Yang YL, Chang CC, Tsai JH, Chuang LY: Effects of high glucose culture on EGF effects and EGF receptors in the LLC-PK1 cells. Am J Nephrol 1997;17:193-198.
36. Guh JY, Lai YH, Shin SJ, Chuang LY, Tsai JH: Epidermal growth factor in renal hypertrophy in streptozotocin-diabetic rats. Nephron 1991;59:641-647.
37. Beenen OH, Pfaffendorf M, van Zwieten PA: Contractile responses to various inotropic agents in isolated hearts obtained from hypertensive diabetic rats. Blood Press 1995;4:372-378.
38. Carter RW, Kanagy NL: Tyrosine kinases regulate intracellular calcium during alpha(2)-adrenergic contraction in rat aorta. Am J Physiol Heart Circ Physiol 2002;283:H1673-H1680.
39. Konishi A, Berk B: Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells. J Biol Chem 2003;278:35049-35056.
40. Yousif MH, Benter IF, Akhtar S: Inhibition of Ras-GTPase improves diabetes-induced abnormal vascular reactivity in the rat perfused mesenteric vascular bed. Med Princ Pract 2004;13:57-62.